Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers
NCT02262559 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2014-10-13
Summary
Study to investigate the bioequivalence of BIBR 277 tablet (Erythritol based) vs. BIBR 277 capsule
Conditions
- Healthy
Interventions
- DRUG
-
BIBR 277 tablet
- DRUG
-
BIBR 277 capsule
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-07-31
- Primary Completion
- 2002-08-31
More Related Trials
-
A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy Participants
NCT03627936 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets
NCT02372097 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations
NCT02596100 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects
NCT05381870 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male Subjects
NCT03070171 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Bioequivalence of a New Nifurtimox Oral Tablet Formulation
NCT03708133 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food
NCT06962826 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers
NCT02260050 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants
NCT02230046 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers
NCT06360081 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body
NCT06393127 ·Status: COMPLETED ·Phase: PHASE1
-
Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers
NCT03533387 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects
NCT06926387 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Two Different Generations of Drug Product of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers
NCT02171520 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans
NCT07331194 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers
NCT01362764 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches
NCT04939779 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Two Different Capsule Types of Dabigatran
NCT01290757 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Trial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese Participants
NCT05877222 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects
NCT06920719 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452
NCT05722262 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Two Different Drug Product Batches of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers
NCT02171013 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Apixaban Tablets in Healthy Chinese Subjects
NCT05841446 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects
NCT01415778 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence And Food Effect Study Comparing The Commercial Formulation Of Crizotinib To Its Clinical Study Formulations And Commercial Formulation With Or Without Food In Healthy Volunteers
NCT01154218 ·Status: COMPLETED ·Phase: PHASE1